Treatment with RBL was effective against recurrent CDI among high-risk patients when administered at home or in clinical settings.

Influenza- and ARI-associated hospitalization rates in adults were highest in those with underlying medical conditions, but the risk was mediated by influenza vaccination.

Arakoda ® (tafenoquine) is now available in an 8-count bottle format, according to 60 Degrees Pharmaceuticals. Arakoda, an 8-aminoquinolone antimalarial, was approved in 2018 for the prophylaxis of ...

For pediatric patients presenting to a hospital, caregiver concern for clinical deterioration is associated with critical illness.

A Texas woman has died after using tap water in a sinus rinse, leading to a rare but often fatal brain infection.

US Health and Human Services Secretary RFK Jr has removed all 17 members of the expert panel that makes US vaccine recommendations.